Dec 25, 2024, 14:49
Akhil Santhosh: Fruquitinib with or without paclitaxel in pretreated advanced gastric cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“FRUTIGA phase 3 RCT: Fruquitinib with or without paclitaxel in pretreated advanced ca stomach.
Median PFS 5.6m vs 2.7m in favour of the combination.
Median OS 9.6m vs 8.4, not statistically significant.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 25, 2024, 14:47
Dec 25, 2024, 14:04
Dec 25, 2024, 13:55
Dec 25, 2024, 13:50
Dec 25, 2024, 13:45
Dec 25, 2024, 13:38